GLS and B-cell non-Hodgkin lymphoma: Despite this, recent findings provide evidence that the glutaminase activity of ASNases is important for the cytotoxic effects on B-ALL cells, as mutant ASNases with abolished glutaminase activity were significantly less cytotoxic to B cell lymphomas when compared to WT ASNases [132, 133].